指南与共识呼吸衰竭与机械通气重症综合管理与镇静镇痛

ICU流感相关肺曲霉病综述及病例定义建议:专家意见

Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.
指南 / 共识 · Intensive Care Med · 2020-06-22
一句话结论国际专家共识提出流感相关肺曲霉病(IAPA)的入组标准和确诊/临床诊断病例定义,以促进临床研究。

目的:ICU中流感患者侵袭性肺曲霉病报告增多,现有侵袭性真菌病定义难以分类IAPA,旨在制定病例定义以促进临床研究。方法:29名国际专家通过非正式共识流程,回顾IAPA流行病学、诊断和管理现状,提出病例定义。结果:入组标准为因呼吸窘迫入住ICU且流感检测阳性与入住ICU时间相关;确诊IAPA需组织学证据和真菌学证据;临床诊断IAPA需BAL或血清GM/培养阳性伴肺部浸润,或上呼吸道培养阳性伴支气管镜支气管炎证据或新发空洞性浸润。结论:提出IAPA共识病例定义,可能有助于研究COVID-19相关肺曲霉病(CAPA)。

要点

  • 入组标准:因呼吸窘迫需入住ICU且流感检测阳性与入住ICU时间相关的患者。
  • 确诊IAPA需组织学显示侵袭性分隔菌丝及曲霉真菌学证据。
  • 临床诊断IAPA:BAL或血清GM或曲霉培养阳性且伴肺部浸润。
  • 临床诊断IAPA:上呼吸道培养阳性且支气管镜见支气管炎或新发空洞性浸润。
  • 该病例定义可能有助于分类COVID-19相关肺曲霉病(CAPA),尚待进一步研究。

适用人群与场景

  • 因呼吸窘迫入住ICU且流感检测阳性与入住ICU时间相关的患者。
  • IAPA可发生于广泛宿主,入组标准不依赖宿主因素。

诊断标准与关键阈值

  • 入组标准:因呼吸窘迫需入住ICU且流感检测阳性与入住ICU时间相关。
  • 确诊IAPA:组织学证据显示侵袭性分隔菌丝及曲霉真菌学证据。
  • 临床诊断IAPA:BAL或血清中检测到半乳甘露聚糖(GM)或曲霉培养阳性,伴肺部浸润;或上呼吸道样本培养阳性,伴支气管镜下支气管炎证据或新发空洞性肺部浸润。

研究设计与关键结果

  • 29名国际专家通过非正式共识流程提出IAPA病例定义,包括入组标准及确诊、临床诊断标准。
  • IAPA病例定义可能用于COVID-19相关肺曲霉病(CAPA)的分类,尚待进一步研究阐明曲霉与SARS-CoV-2感染肺的相互作用。

证据类型、等级与局限

  • 证据类型:国际专家非正式共识(专家意见)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对因呼吸窘迫入住ICU且流感检测阳性的患者,可按本共识病例定义评估IAPA。
  • 该病例定义可能有助于临床研究中对IAPA和CAPA的分类,作者认为仍需进一步研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Invasive pulmonary aspergillosis is increasingly reported in patients with influenza admitted to the intensive care unit (ICU). Classification of patients with influenza-associated pulmonary aspergillosis (IAPA) using the current definitions for invasive fungal diseases has proven difficult, and our aim was to develop case definitions for IAPA that can facilitate clinical studies.

METHODS: A group of 29 international experts reviewed current insights into the epidemiology, diagnosis and management of IAPA and proposed a case definition of IAPA through a process of informal consensus.

RESULTS: Since IAPA may develop in a wide range of hosts, an entry criterion was proposed and not host factors. The entry criterion was defined as a patient requiring ICU admission for respiratory distress with a positive influenza test temporally related to ICU admission. In addition, proven IAPA required histological evidence of invasive septate hyphae and mycological evidence for Aspergillus. Probable IAPA required the detection of galactomannan or positive Aspergillus culture in bronchoalveolar lavage (BAL) or serum with pulmonary infiltrates or a positive culture in upper respiratory samples with bronchoscopic evidence for tracheobronchitis or cavitating pulmonary infiltrates of recent onset. The IAPA case definitions may be useful to classify patients with COVID-19-associated pulmonary aspergillosis (CAPA), while awaiting further studies that provide more insight into the interaction between Aspergillus and the SARS-CoV-2-infected lung.

CONCLUSION: A consensus case definition of IAPA is proposed, which will facilitate research into the epidemiology, diagnosis and management of this emerging acute and severe Aspergillus disease, and may be of use to study CAPA.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Verweij PE, Rijnders BJA, Brüggemann RJM, et al. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020. PMID: 32572532. doi:10.1007/s00134-020-06091-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。